SwePub
Sök i LIBRIS databas

  Extended search

(hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin)) pers:(Ahrén Bo)
 

Search: (hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin)) pers:(Ahrén Bo) > (2010-2014) > Effects of increasi...

  • Chan, Hui Min (author)

Effects of increasing doses of glucagon-like peptide-1 on insulin-releasing phases during intravenous glucose administration in mice

  • Article/chapterEnglish2011

Publisher, publication year, extent ...

  • American Physiological Society,2011

Numbers

  • LIBRIS-ID:oai:lup.lub.lu.se:a72fe7a2-1a9d-4d12-a154-28eff3a5d9b9
  • https://lup.lub.lu.se/record/1988169URI
  • https://doi.org/10.1152/ajpregu.00687.2010DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:art swepub-publicationtype
  • Subject category:ref swepub-contenttype

Notes

  • Chan HM, Jain R, Ahren B, Pacini G, D'Argenio DZ. Effects of increasing doses of glucagon-like peptide-1 on insulin-releasing phases during intravenous glucose administration in mice. Am J Physiol Regul Integr Comp Physiol 300: R1126-R1133, 2011. First published February 9, 2010; doi:10.1152/ajpregu.00687.2010.-The increase in insulin secretion caused by glucagon-like peptide-1 (GLP-1) and GLP-1 mimetics observed during an intravenous glucose test (IVGTT) has been reported in both normal and disease animal models, as well as in humans. In this study, a hierarchical population modeling approach is used, together with a previously reported model relating glucose to insulin appearance, to determine quantitative in vivo dose-response relationships between GLP-1 dose level and both first-and second-phase insulin release. Parameters of the insulin kinetic model were estimated from the complete set of glucose and insulin data collected in 219 anesthetized nonfasted NMR-imaged mice after intravenous injection of glucose (1 g/kg) alone or with GLP-1 (0.03-100 nmol/kg). The resulting dose-response curves indicate a difference in GLP-1 effect on the two release phases, as is also evident from the different ED50 parameter values (0.107 vs. 6.65 nmol/kg for phase 1 vs. phase 2 insulin release parameters). The first phase of insulin release is gradually augmented with increasing GLP-1 dose, reaching saturation at a dose of similar to 1 nmol/kg, while the second-phase release changes more abruptly at GLP-1 doses between 3 and 10 nmol/kg and shows a more pronounced 100-fold increase between control and the high GLP-1 dose of 100 nmol/kg Moreover, separate disposition indices calculated for phase 1 and 2 insulin release, show a different pattern of increase with increasing GLP-1 dose.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Jain, Ritesh (author)
  • Ahrén, BoLund University,Lunds universitet,Medicin, Lund,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Medicine, Lund,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)med-bah (author)
  • Pacini, Giovanni (author)
  • D'Argenio, David Z. (author)
  • Medicin, LundSektion II (creator_code:org_t)

Related titles

  • In:American Journal of Physiology: Regulatory, Integrative and Comparative Physiology: American Physiological Society300:5, s. 1126-11330363-61191522-1490

Internet link

Find in a library

To the university's database

Find more in SwePub

By the author/editor
Chan, Hui Min
Jain, Ritesh
Ahrén, Bo
Pacini, Giovanni
D'Argenio, David ...
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Other Clinical M ...
Articles in the publication
American Journal ...
By the university
Lund University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view